Picture of Aptevo Therapeutics logo

APVO — Aptevo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aptevo Therapeutics Reports Qtrly Loss Per Share of $1.43

Nov 12 (Reuters) - Aptevo Therapeutics Inc  APVO.O :
    * APTEVO THERAPEUTICS INC - QTRLY LOSS PER SHARE OF $1.43
    * APTEVO THERAPEUTICS INC - RESTRICTED CASH OF $1.3 MILLION
AS OF
SEPTEMBER 30, 2021 IS EXPECTED TO BE RELEASED OVER NEXT TWELVE
MONTHS

Further company coverage:  APVO.O 

 (Reporting by Nandhini Srinivasan)
 ((Nandhini.Srinivasan@thomsonreuters.com;))

Recent news on Aptevo Therapeutics

See all news